Proximal Ventures raises debut fund to back startups bringing AI to drug development

Former SignalFire investor Sahir Raoof raises $27.5 million for new fund targeting AI in pharma.

Proximal Ventures raises debut fund to back startups bringing AI to drug development
Former SignalFire investor Sahir Raoof raises $27.5 million for new fund targeting AI in pharma.

Share